BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23856214)

  • 21. C4d analysis in endomyocardial biopsies of heart transplant patients: is there a correlation with hemodynamic data?
    Boffini M; Ricci D; Bonato R; Ribezzo M; Simonato E; Saviolo R; Checco L; Comoglio C; Rinaldi M
    Transplant Proc; 2011 May; 43(4):1168-70. PubMed ID: 21620080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody.
    Hodges AM; Lyster H; McDermott A; Rice AJ; Smith JD; Rose ML; Banner NR
    Transplantation; 2012 Mar; 93(6):650-6. PubMed ID: 22245878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation.
    Kfoury AG; Renlund DG; Snow GL; Stehlik J; Folsom JW; Fisher PW; Reid BB; Clayson SE; Gilbert EM; Everitt MD; Bader FM; Singhal AK; Hammond ME
    J Heart Lung Transplant; 2009 Jan; 28(1):51-7. PubMed ID: 19134531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of circulating donor specific antibody to predict biopsy diagnosis of antibody-mediated rejection and to provide prognostic value after heart transplantation in children.
    Ware AL; Malmberg E; Delgado JC; Hammond ME; Miller DV; Stehlik J; Kfoury A; Revelo MP; Eckhauser A; Everitt MD
    J Heart Lung Transplant; 2016 Feb; 35(2):179-85. PubMed ID: 26520246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation.
    Kfoury AG; Snow GL; Budge D; Alharethi RA; Stehlik J; Everitt MD; Miller DV; Drakos SG; Reid BB; Revelo MP; Gilbert EM; Selzman CH; Bader FM; Connelly JJ; Hammond ME
    J Heart Lung Transplant; 2012 Jan; 31(1):46-51. PubMed ID: 22153551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemistry staining of C4d to diagnose antibody-mediated rejection in cardiac transplantation.
    Fedson SE; Daniel SS; Husain AN
    J Heart Lung Transplant; 2008 Apr; 27(4):372-9. PubMed ID: 18374872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.
    Ho EK; Vlad G; Vasilescu ER; de la Torre L; Colovai AI; Burke E; Deng M; Schwartz J; Marboe C; Mancini D; Opelz G; Suciu-Foca N
    Hum Immunol; 2011 Jan; 72(1):5-10. PubMed ID: 20971146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of the Quilty effect in endomyocardial biopsy of patients after heart transplantation - from cellular rejection to antibody-mediated rejection?
    Szymanska S; Grajkowska W; Sobieszczanska-Malek M; Zielinski T; Pyzlak M; Pronicki M
    Pol J Pathol; 2016; 67(3):216-220. PubMed ID: 28155969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Building a tissue-based molecular diagnostic system in heart transplant rejection: The heart Molecular Microscope Diagnostic (MMDx) System.
    Halloran PF; Potena L; Van Huyen JD; Bruneval P; Leone O; Kim DH; Jouven X; Reeve J; Loupy A
    J Heart Lung Transplant; 2017 Nov; 36(11):1192-1200. PubMed ID: 28662985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
    Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome.
    Worthington JE; McEwen A; McWilliam LJ; Picton ML; Martin S
    Transplantation; 2007 Feb; 83(4):398-403. PubMed ID: 17318071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.
    Lobo LJ; Aris RM; Schmitz J; Neuringer IP
    J Heart Lung Transplant; 2013 Jan; 32(1):70-7. PubMed ID: 23260706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patients.
    Dijke IE; Velthuis JH; Caliskan K; Korevaar SS; Maat AP; Zondervan PE; Balk AH; Weimar W; Baan CC
    Transplantation; 2007 Jun; 83(11):1477-84. PubMed ID: 17565321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy.
    Loupy A; Cazes A; Guillemain R; Amrein C; Hedjoudje A; Tible M; Pezzella V; Fabiani JN; Suberbielle C; Nochy D; Hill GS; Empana JP; Jouven X; Bruneval P; Duong Van Huyen JP
    Am J Transplant; 2011 Jul; 11(7):1478-87. PubMed ID: 21668629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes.
    Gandhi MJ; DeGoey SR; Bundy K; Kremers WK; Knauer R; Pereira N; Edwards B; Kushwaha S; Daly RC
    Transplant Proc; 2011 Dec; 43(10):3840-6. PubMed ID: 22172857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Assessment of Microcirculation Injury in Formalin-Fixed Human Cardiac Allograft Biopsies With Antibody-Mediated Rejection.
    Afzali B; Chapman E; Racapé M; Adam B; Bruneval P; Gil F; Kim D; Hidalgo L; Campbell P; Sis B; Duong Van Huyen JP; Mengel M
    Am J Transplant; 2017 Feb; 17(2):496-505. PubMed ID: 27401781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD68/CD31 immunohistochemistry double stain demonstrates increased accuracy in diagnosing pathologic antibody-mediated rejection in cardiac transplant patients.
    Glass C; Butt YM; Gokaslan ST; Torrealba JR
    Am J Transplant; 2019 Nov; 19(11):3149-3154. PubMed ID: 31339651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C4D immunostaining in surveillance endomyocardial biopsies from well-functioning heart allografts.
    Arias LF; Fernández R; Fernández D; Jaramillo JC; Gil M; López García-Asenjo JA
    Transplant Proc; 2010 Jun; 42(5):1793-6. PubMed ID: 20620525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
    Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
    Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early findings after integration of donor-derived cell-free DNA into clinical care following pediatric heart transplantation.
    Feingold B; Rose-Felker K; West SC; Zinn MD; Berman P; Moninger A; Huston A; Stinner B; Xu Q; Zeevi A; Miller SA
    Pediatr Transplant; 2022 Feb; 26(1):e14124. PubMed ID: 34420244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.